MACARTNEY LAWSON
SEC insider (Form 3/4/5 filer). CIK 0001606831. Director at Viking Therapeutics, Inc. (VKTX). 4 reported Form 4/5 transactions since Sep 2024; latest on Jan 2, 2026. Located in SAN DIEGO, CA.
Companies MACARTNEY LAWSON has filed insider reports for
- Viking Therapeutics, Inc. (VKTX): Director
MACARTNEY LAWSON
CIK: 0001606831
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (25.0%)
Position reduction
Option Exercises (M)1 (25.0%)
Derivative conversions
Awards (A)2 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
VKTX
Viking Therapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jan 2, 2026VKTX
Viking Therapeutics, Inc.
AwardDirect3.2K shares- - Jan 2, 2025VKTX
Viking Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
18.8K shares- - Nov 8, 2024VKTX
Viking Therapeutics, Inc.
ExerciseDirect2K shares at avg. $5.80$12K - Nov 8, 2024VKTX
Viking Therapeutics, Inc.
SaleDirect2K shares at avg. $68.67$137K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 2, 2026 | VKTX Viking Therapeutics, Inc. | Award | 3,150 | - | $0 | Direct |
| Jan 2, 2025 | VKTX Viking Therapeutics, Inc. | Award Stock Option (Right to Buy) | 18,800 | - | - | Direct |
| Nov 8, 2024 | VKTX Viking Therapeutics, Inc. | Exercise | 2,000 | $5.80 | $11,600 | Direct |
| Nov 8, 2024 | VKTX Viking Therapeutics, Inc. | Sale | 2,000 | $68.67 | $137,333 | Direct |
1-4 of 4 transactions